Merck & Co., Inc. (MRK) Announces Completion of NovaCardia, Inc. Acquisition
9/11/2007 10:09:39 AM
More...
|
Merck & Co., Inc. (MRK) (Jobs) to Buy NovaCardia, Inc. for $350 Million to Expand Heart Drug Pipeline
7/25/2007 8:11:16 AM
More...
|
Pilot Phase 3 Results of NovaCardia, Inc.'s KW-3902 for Acute Congestive Heart Failure Presented at Late-Breaking Session of Heart Failure Congress 2007
6/11/2007 10:35:47 AM
More...
|
The Day In Review: Novartis Corporation (NVS) Pulls Zelnorm Off The Market
3/30/2007 5:49:45 PM
More...
|
NovaCardia, Inc. Files for $86.25 Million IPO
3/30/2007 10:35:32 AM
More...
|
NovaCardia, Inc. Appoints Joseph L. Turner To Its Board Of Directors
2/6/2007 12:11:24 PM
More...
|
NovaCardia, Inc. Appoints John E. Crawford As Chief Financial Officer
1/4/2007 12:24:34 PM
More...
|
NovaCardia, Inc. Presents Phase II Data For KW-3902 At American Heart Association's 79th Annual Scientific Sessions
11/14/2006 12:06:25 PM
More...
|
NovaCardia, Inc. Raises $48 Million In Series B
9/25/2006 8:43:28 AM
More...
|
NovaCardia, Inc. Presents Positive Results Of Two Phase II Trials In Late-Breaking Trials Session At Heart Failure 2006 Congress
6/19/2006 11:21:16 AM
More...
|
|